Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederdrugs.com
Drugs.com - New Drug Approvals
Get the latest updates from Drugs.com - New Drug Approvals directly as they happen.
Follow now 78 followers
Latest posts
Last updated 4 days ago
ADMA Biologics Announces FDA Approval to Expand the Label for Asceniv to Include Pediatric Immune Compromised Patients Two Years of Age and Older
5 days ago
RAMSEY, N.J. and BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) --...
FDA Approves Langlara (insulin glargine-aldy), an Interchangeable Biosimilar to Lantus
5 days ago
PHILADELPHIA - May 4, 2026 - Lannett Company, Inc., Lanexa Biologics, a...
FDA Approves Langlara (insulin glargine-aldy) an Interchangeable Biosimilar to Lantus
5 days ago
PHILADELPHIA - May 4, 2026 - Lannett Company, Inc., Lanexa Biologics, a...
Incyte Announces FDA Approval of Jakafi XR (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease
8 days ago
WILMINGTON, Del.--(BUSINESS WIRE)--May 1, 2026-- Incyte (Nasdaq:INCY) today announced that the U.S...
FDA Approves Veppanu (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
8 days ago
NEW HAVEN, Conn., May 01, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq...
ADMA Biologics Announces FDA Approval to Expand the Label for Asceniv to Include Pediatric Immune Compromised Patients Two Years of Age and Older
9 days ago
RAMSEY, N.J. and BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) --...
Axsome Therapeutics Announces FDA Approval of Auvelity (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease
9 days ago
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ...
FDA Approves Langlara (insulin glargine-aldy), an Interchangeable Biosimilar to Lantus
10 days ago
PHILADELPHIA - May 4, 2026 - Lannett Company, Inc., Lanexa Biologics, a...
Breztri Approved in the US for Asthma as First and Only Triple Therapy for Patients 12 Years of Age and Older
11 days ago
April 28, 2026 -- AstraZeneca’s fixed-dose triple-combination therapy Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate...
Saphnelo Approved in the US for Subcutaneous Self-Administration as a New Autoinjector for the Treatment of Systemic Lupus Erythematosus
12 days ago
27 April 2026 -- AstraZeneca’s Saphnelo (anifrolumab) has been approved in the...
FDA Approves Caplyta (lumateperone) sNDA with Robust New Data Supporting Reduced Risk of Relapse in Schizophrenia
12 days ago
TITUSVILLE, N.J. (APRIL 27, 2026) – Johnson & Johnson announced today that...
FDA Grants Accelerated Approval for Otarmeni (lunsotogene parvec-cwha) Gene Therapy for Genetic Hearing Loss
16 days ago
TARRYTOWN, N.Y., April 23, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ...